Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07046000 · ClinicalTrials.gov registry record
MRI Evaluation of Graft Maturation Following ACL Reconstruction
A clinical trial, sponsored by Skye Biologics Holdings.
- Not yet
- Registry status
- 10
- Enrollment target
NCT07046000: Clinical Trial study, sponsored by Skye Biologics Holdings.
NCT07046000 is a clinical trial that has not yet begun recruiting, run by Skye Biologics Holdings. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07046000 has not yet begun recruiting, sponsored by Skye Biologics Holdings.
- NOT YET RECRUITING
- Registry status
- 10 participants
- Enrollment target
Study Summary
Post-surgical ACL Graft maturation will be assessed at 4.5, 6, 7.5, 9, 10.5, and 12 months with MRI.
Primary Outcome
The signal to noise ratio will be calculated at the proximal, mid-substance, and distal positions of the graft
Interventions
- DIAGNOSTIC_TEST MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2026-08-01 |
| Est. Completion | 2028-02 |
What is known before NCT07046000 opens enrollment
NCT07046000 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which MRI is the first listed.
NCT07046000 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07046000 about?
NCT07046000 is a clinical study titled "MRI Evaluation of Graft Maturation Following ACL Reconstruction". Post-surgical ACL Graft maturation will be assessed at 4.5, 6, 7.5, 9, 10.5, and 12 months with MRI.
What is the current status of trial NCT07046000?
This trial is currently not yet recruiting. The enrollment target is 10 participants. The study started on 2026-08-01. Estimated completion is 2028-02.
What interventions are being tested in trial NCT07046000?
The interventions under investigation include: MRI (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07046000?
This trial is sponsored by Skye Biologics Holdings, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI